Ropes & Gray represented GHO Capital in the sale of its stake in BioAgilytix, a leading global contract research organization (CRO), to Cinven. Cinven will acquire a majority stake in BioAgilytix while current majority investor Cobepa, S.A. will remain a minority investor in the company. Terms of the transaction were not disclosed. The transaction was announced on Nov. 17 in a press release.
BioAgilytix is a global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. Global Healthcare Opportunities, or GHO Capital Partners LLP, is a leading specialist healthcare investment advisor based in London.
The Ropes & Gray team that advised GHO Capital Partners LLP included private equity partners Neill Jakobe and Tim Castelli (both of Chicago), private equity associate Andrew Pomranke (Chicago) and tax partner Elaine B. Murphy (Boston).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.